Alexza Pharmaceuticals, Inc. Reports 2012 Fourth Quarter and Full Year Financial Results

Published: Mar 27, 2013

MOUNTAIN VIEW, Calif., March 26, 2013 -- /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter and full year ended December 31, 2012. The net loss for the quarters ended December 31, 2012 and 2011, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $10.3 million and $9.7 million, respectively.

Back to news